Repligen Corporation
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding com…
Medical - Instruments & Supplies
US, Waltham [HQ]
Ratios
14 Records · Starting from 2010Margins, Growth Rates In %
| Ratio | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||
| Gross Margin | 73.74 | 73.92 | 56.36 | 63.09 | 55.90 | 57.80 | 54.93 | 52.53 | 55.70 | 55.93 | 57.23 | 58.35 | 56.85 | 44.50 | |
| Profit Margin | -19.38 | -0.16 | 22.73 | 23.61 | 12.86 | 11.19 | 11.17 | 20.07 | 8.56 | 7.92 | 16.36 | 19.13 | 23.20 | 6.51 | |
| Operating Margin | -27.50 | -1.37 | 17.80 | 33.55 | 16.82 | 16.48 | 15.28 | 9.92 | 13.39 | 5.51 | 11.62 | 19.91 | 16.67 | 9.91 | |
|
EPS Growth
|
-168.42 | 98.92 | 32,957.14 | 10.87 | -50.98 | 12.00 | 25.00 | 111.43 | -48.65 | 15.79 | 159.09 | 104.39 | 43.78 | -77.61 | |
| EPS USD | -13.00 | -0.14 | 46.00 | 51.00 | 25.00 | 28.00 | 35.00 | 74.00 | 38.00 | 44.00 | 114.00 | 233.00 | 335.00 | 75.00 | |
| Return on Assets (ROA) | -5.69 | -0.06 | 14.59 | 13.56 | -12.49 | 6.39 | 4.04 | 23.55 | 11.92 | 1.53 | 3.15 | 5.44 | 7.37 | 1.47 | |
| Return on Equity (ROE) | -6.15 | -0.06 | 16.83 | 15.49 | -10.10 | 7.61 | -19.51 | -89.99 | -106.74 | 366.44 | 91.12 | 7.33 | 46.81 | 2.11 | |
| Return on Invested Capital (ROIC) | -7.24 | 3.68 | 16.55 | 15.40 | -9.69 | 7.81 | 45.07 | 80.87 | 10.52 | 4.53 | 12.62 | 5.27 | 13.82 | 1.61 | |
| Solvency | |||||||||||||||
| Equity Ratio | - - | - - | - - | - - | 100 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | - - | - - | - - | - - | - - | - - | 32.98 | 82.43 | 148.42 | 18.81 | 14.47 | 15.52 | 16.75 | 20.72 | |
| Debt/Equity | - - | - - | - - | - - | - - | - - | -159.16 | -315.00 | -1,329.50 | 4,506.57 | 418.76 | 20.92 | 106.47 | 29.69 | |
| Debt/EBITDA | 285.48 | -1,092.20 | -256.09 | -174.28 | -478.75 | -421.83 | -253.37 | -559.46 | -344.13 | -741.07 | -634.80 | -138.28 | -54.44 | -30.08 | |
|
Debt/Capitalization
|
- - | - - | - - | - - | - - | - - | 269.05 | 146.51 | 108.13 | 97.83 | 80.72 | 17.30 | 51.57 | 22.89 | |
| Long-Term Debt/Capitalization | - - | - - | - - | - - | - - | - - | 269.05 | 146.51 | 117.71 | 97.80 | 28.66 | 5.53 | 24.85 | 20.56 | |
| Interest Debt per Share USD | - - | - - | - - | - - | - - | - - | 2.95 | 2.76 | 4.88 | 5.64 | 5.47 | 6.88 | 7.65 | 10.68 | |
| Debt Growth | - - | - - | - - | - - | - - | - - | - - | 4.18 | 4.27 | 154.44 | 4.59 | 32.91 | 15.55 | 68.29 | |
| Liquidity | |||||||||||||||
| Current Ratio | 1,281.50 | 1,207.93 | 615.77 | 764.09 | 757.75 | 549.77 | 873.80 | 963.00 | 212.37 | 1,328.48 | 282.92 | 248.27 | 246.94 | 702.47 | |
| Quick Ratio | 1,202.47 | 1,155.00 | 497.43 | 651.70 | 872.40 | 545.95 | 841.70 | 799.24 | 176.81 | 1,184.08 | 247.27 | 192.19 | 183.08 | 553.54 | |
| Cash Ratio | 268.96 | 307.23 | 271.66 | 352.44 | 580.43 | 390.86 | 672.74 | 689.22 | 149.28 | 1,093.68 | 224.89 | 160.90 | 129.51 | 475.03 | |
| Operating Cash Flow Ratio | - - | - - | 100 | 200 | 100 | - - | - - | - - | - - | 100 | - - | - - | - - | - - | |
| Turnover | |||||||||||||||
| Inventory Turnover | 250.15 | 364.25 | 243.82 | 213.27 | 226.28 | 195.86 | 190.79 | 171.91 | 203.38 | 217.21 | 164.84 | 151.38 | 145.14 | 175.23 | |
| Receivables Turnover | 731.71 | 723.48 | 463.65 | 566.81 | 784.54 | 729.90 | 650.86 | 509.18 | 542.70 | 618.81 | 513.05 | 571.06 | 689.51 | 514.46 | |
| Payables Turnover | 555.62 | 764.82 | 1,107.08 | 1,461.74 | 725.33 | 524.26 | 930.98 | 920.76 | 819.46 | 1,042.44 | 927.93 | 771.43 | 1,255.10 | 1,812.18 | |
|
Asset Turnover
|
29.36 | 37.75 | 64.19 | 57.46 | -97.13 | 57.12 | 36.18 | 117.30 | 139.14 | 19.30 | 19.25 | 28.43 | 31.75 | 22.62 | |
| Fixed Turnover | 669.36 | 1,265.63 | 625.64 | 544.95 | 437.47 | 605.30 | 698.99 | 630.04 | 602.96 | 364.40 | 397.91 | 296.01 | 253.89 | 197.79 | |
| Coverage | |||||||||||||||
| Interest Coverage | -292,428.04 | -1,429.55 | 19,542.11 | 45,885.05 | 21,400.55 | 43,012.50 | 423.94 | 217.44 | 387.36 | 160.36 | 350.63 | 1,050.02 | 11,498.28 | 631.42 | |
| Asset Coverage | - - | - - | - - | - - | - - | - - | 200 | - - | - - | 400 | 500 | 500 | 400 | 300 | |
| Cash Flow Coverage (CFGR) | - - | - - | - - | - - | - - | - - | 7.89 | 17.58 | 15.83 | 25.53 | 22.74 | 32.51 | 40.69 | 19.47 | |
| EBITDA Coverage | -222,400 | 4,900 | 20,100 | 45,800 | 25,900 | 54,300 | 400 | 200 | 300 | 300 | 500 | 1,300 | 15,800 | 1,300 | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | - - | - - | 100 | 200 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |
| Market Prospects | |||||||||||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | -3.26 | -0.04 | 7.29 | 3.73 | 1.27 | 1.01 | 1.13 | 2.04 | 0.72 | 0.48 | 0.60 | 0.88 | 1.98 | 0.42 | |
|
Price/Earnings (P/E)
|
-30.7230 | -2,645.9867 | 13.7145 | 26.8399 | 78.7560 | 99.5431 | 88.5814 | 48.9236 | 138.9102 | 208.8519 | 168.0560 | 113.5713 | 50.4946 | 240.9615 | |
| Price/Earnings Growth (PEG) | 18.24 | 2,674.79 | -0.04 | 246.93 | -154.48 | 829.53 | 354.33 | 43.91 | -285.54 | 1,322.73 | 105.64 | 108.80 | 115.35 | -310.47 | |
|
Price/Book (P/B)
|
188.83 | 171.61 | 230.78 | 415.78 | -795.49 | 757.84 | -1,728.54 | -4,402.47 | -14,827.03 | 76,531.36 | 15,312.57 | 832.55 | 2,363.60 | 508.24 | |
| Price/Tangible Book (P/TB) | 188.83 | 171.61 | 230.78 | 415.78 | -795.49 | 757.84 | -1,728.54 | -4,402.47 | -14,827.03 | 76,531.36 | 15,312.57 | 832.55 | 2,363.60 | 508.24 | |
| Price/Sales (P/S) | 595.36 | 421.84 | 311.79 | 633.62 | 1,012.54 | 1,113.55 | 989.77 | 982.14 | 1,189.63 | 1,654.69 | 2,749.66 | 2,172.92 | 1,171.49 | 1,568.41 | |
|
Price/Cash Flow (P/CF)
|
-5,099.48 | 3,562.27 | 1,444.56 | 1,665.79 | 3,496.78 | 6,179.70 | 13,757.74 | 7,948.71 | 7,043.86 | 6,652.77 | 16,081.31 | 12,242.20 | 5,456.63 | 8,794.45 | |
| Price/Free CF (P/FCF) | -4,099.33 | 4,252.68 | 1,594.47 | 2,028.34 | 5,027.47 | 7,486.76 | 32,375.46 | 11,562.30 | 12,321.95 | 10,148.72 | 27,758.12 | 30,519.84 | 24,240.22 | 13,370.42 | |
| Price/Operating CF (P/OCF) | -5,099.48 | 3,562.27 | 1,444.56 | 1,665.79 | 3,496.78 | 6,179.70 | 13,757.74 | 7,948.71 | 7,043.86 | 6,652.77 | 16,081.31 | 12,242.20 | 5,456.63 | 8,794.45 |